Skip to main content

Advertisement

SpringerLink
Log in

The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The change of cell mobility is one of the preconditions of tumor metastasis. Cell skeleton alteration and rearrangement of F-actin was closely related to cell mobility. Ezrin is a membrane-cytoskeleton organizer that can mediate the rearrangement and the function of F-actin. In this paper, we investigated the effect of ezrin on hepatocellullar carcinoma cell growth and invasiveness.

Methods

Hepatocellular carcinoma cell lines such as MHCC-1, MHCC97-H, SF7721, SMMC7721, Hep3B, and HepG2 were chosen in this study. We first examined the expression and the distribution of ezrin and F-actin in these cell lines using immunofluorescence, RT–PCR, and the western blot. Next we used small interfering RNA (siRNA) to down-regulate ezrin expression in MHCC-1, MHCC97-H, SF7721, and HepG2 to investigate the role of ezrin in tumor cell growth and invasiveness.

Results

Our preliminary results showed that the expression of ezrin and γ-actin in MHCC-1, MHCC97-H, and SF7721 with higher metastatic potential were obviously up-regulated than those in SMMC7721, Hep3B, and HepG2 with lower potential. No different expression of β-actin was found in the above tumor cell lines. The outcome of RNAi indicated that decreasing ezrin expression can notably inhibit the proliferation of the four hepatocellular carcinoma cell lines (p < 0.01, n = 10). The proportion of cells in G2-M phase also decreased after RNAi. The number of pseudopods decreased as well after RNAi treatment (p < 0.01, n = 5). The mobility and invasiveness of cancer cells decreased with decreasing ezrin expression tested by transwell assay (p < 0.01, n = 8).

Conclusion

Ezrin plays an important role in the process of hepatocellular carcinoma cell proliferation, migration, and invasiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Andreoli C, Martin M, Le Borgne R, Reggio H, Mangeat P (1994). Ezrin has properties to self-associate at the plasma membrane. J Cell Sci 107(9):2509–2521

    PubMed  CAS  Google Scholar 

  • Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586–599

    Article  PubMed  CAS  Google Scholar 

  • Chen ZC, Fadiel A, Feng YJ, Ohtani K, Rutherford T, Naftolin F (2001) Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1 alpha and epidermal growth factor. Cancer 92:3068–3075

    Article  PubMed  CAS  Google Scholar 

  • Crepaldi T, Gautreau A, Comoglio PM, Louvard D, Arpin M (1997) Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cell. J Cell Biol 138(2):423–434

    Article  PubMed  CAS  Google Scholar 

  • Harrision GM, Davies G, Martin TA (2002) Distribution and expression of CD44 isoforms and ezrin during prostate cancer–endothelium interaction. Int J Oncol 21:935–940

    Google Scholar 

  • Hiscox S, Jiang WG (1999) Ezrin regulates cell–cell and cell–matrix adhesion: a possible role with E-cadherin/beta-catenin. J Cell Sci 112(18):3081–3090

    PubMed  CAS  Google Scholar 

  • Kaul SC, Mitsui Y, Komatsu Y, Reddel RR, Wadhwa R (1996) A highly expressed 81 kDa protein in immortalized mouse fibroblast: its proliferative function and identity with ezrin. Oncogene 13(6):1231–1237

    PubMed  CAS  Google Scholar 

  • Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10(2):182–186

    Article  PubMed  CAS  Google Scholar 

  • Krieg J, Hunter T (1992) Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 267:19258–19265

    PubMed  CAS  Google Scholar 

  • Lamb RF, Ozanne BW, Roy C, McGarry L, Stipp C, Mangeat P, Jay DG (1997) Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts. Curr Biol 7(9):682–688

    Article  PubMed  CAS  Google Scholar 

  • Masahide T, Toshiro N, Yukihito S (2000) Altered expression of the ERM proteins in lung adenocarcinoma. US Can Acad Pathol 80(11):1643–1650

    Google Scholar 

  • Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140:647–657

    Article  PubMed  CAS  Google Scholar 

  • Nguyen R, Reczek D, Bretscher A (2001) Hierarchy of merlin and ezrin N and C-terminal domain interactions in homo and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J Biol Chem 276:7621–7629

    Article  PubMed  CAS  Google Scholar 

  • Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F (1999) Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 147(1/2):31–38

    Article  PubMed  CAS  Google Scholar 

  • Pawlak G, Helfman DM (2000) Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11(1):41–47

    Article  Google Scholar 

  • Sainio M, Zhao F, Heiska L, Turunen O, den Bakker M, Zwarthoff E, Lutchman M, Rouleau GA, Jaaskelainen J, Vaheri A, Carpen O (1997) Neurofibromatosis 2 tumour suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 110:2249–2260

    PubMed  CAS  Google Scholar 

  • Shen ZY, Xu LY, Chen MH, Li EM, Li JT, Wu XY, Zeng Y, Xu LY, Chen MH, et al. (2003) Upregulated expression of ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J Gastroenterol 9(6):1182–1186

    PubMed  CAS  Google Scholar 

  • Small JV (1994) Lamellipodia architecture: actin filament turnover and the lateral flow of actin filaments during motility. Semin Cell Biol 5:157–163

    Article  PubMed  CAS  Google Scholar 

  • Small JV, Rottner K, Kaverina I, Anderson KI (1998) Assembling an actin cytoskeleton for cell attachment and movement. Biochim Biophys Acta 1404:271–281

    Article  PubMed  CAS  Google Scholar 

  • Small JV, Stradal T, Vignal E, Rottner K (2002) The lamellipodium: where motility begins. Trends Cell Biol 12:112–120

    Article  PubMed  CAS  Google Scholar 

  • Tran Quang C, Gautreau A, Arpin M, Treisman R (2000) Ezrin function is required for ROCK-mediated fibroblast transformation by the net and dbl oncogenes. EMBO J 19:4565–4576

    Article  PubMed  CAS  Google Scholar 

  • Xie Q, Liu KD, Hu MY, Zhou K (2001) SF/HCF-c-met autocrine and paracrine promote metastasis in hepatocellular carcinoma. World J Gastroenterol 7:816–820

    PubMed  CAS  Google Scholar 

  • Yonemura S, Tsukita S, Tsukita S (1999) Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins in the organization of microvilli in collaboration with activated ERM proteins. J Cell Biol 145(7):1497–1509

    Article  PubMed  CAS  Google Scholar 

  • Yonemura S, Matsui T, Tsukita S (2002) Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo. J Cell Sci 115:2569–2580

    PubMed  CAS  Google Scholar 

  • Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastasic regulators. Nat Med 10(2):175–181

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, 200032, China

    Yan Zhang, Mei-Yu Hu, Zhi-Jun Wang, Kang Zhou & Kang-Da Liu

  2. Liver Cancer Institute, Fudan University, Shanghai, China

    Wei-Zhong Wu

  3. Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, China

    Xi-Liang Zha

Authors
  1. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mei-Yu Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei-Zhong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhi-Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xi-Liang Zha
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kang-Da Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kang-Da Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Y., Hu, MY., Wu, WZ. et al. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol 132, 685–697 (2006). https://doi.org/10.1007/s00432-006-0117-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-006-0117-5

Keywords

Search

Navigation